Clinical Trial

YN001-004 in Patients With Coronary Atherosclerosis in Australia

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is to evaluate the efficacy and safety of intravenously administered YN001 in patients with coronary atherosclerosis in Australia. This study will be conducted in eligible participants with a diagnosis of coronary atherosclerosis, and at least 1 coronary artery is blocked determined by coronary computed tomography angiography (CCTA)
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-11-19; most recent amendment 2026-02-12.
Status change: Not Yet Recruiting → Recruiting 2025-02-05
Trial Details
NCT Number NCT06700720
Lead Sponsor Beijing Inno Medicine Co., Ltd.
Conditions Coronary Artery Disease, Coronary Atherosclerotic Disease
Enrollment 24 participants
Start Date 2026-02
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-17